checkAd
    Startseite > Aktien > ORHub > Nachrichten
    ORHub Aktie
    0,0349
     
    USD
    +2,65 %
    +0,0009 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: US68620R1077 · WKN: A2DQTX · SYM: ORHB · USA

    Neueste Nachrichten

    HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New Year
    11.12.23 · Accesswire · ORHub
    HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities
    05.12.23 · Accesswire · ORHub
    Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization
    07.11.23 · Accesswire · ORHub
    International Sales Win for PUR Biologics
    24.10.23 · Accesswire · ORHub
    PUR Biologics Secures Innovative Medical Patent with Strong Financial Upside
    12.09.23 · Accesswire · ORHub
    HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation
    06.09.23 · Accesswire · ORHub
    HippoFi To Announce Strategic Alliance With Orthopedic Industry Leader
    01.09.23 · Accesswire · ORHub
    US Patent Office Issues New Patent to PUR Biologics for Advanced Cartilage Regeneration and Arthritis Solutions
    14.08.23 · Accesswire · ORHub
    HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica
    09.08.23 · Accesswire · ORHub
    HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market
    25.07.23 · Accesswire · ORHub
    HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device
    25.07.23 · Accesswire · ORHub
    HippoFi's PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States
    27.06.23 · Accesswire · ORHub